Dr. Mario Sofer is a leading Israeli endourologist. He has extensive experience in endoscopic interventions on the genitourinary tract (mechanical injuries, hereditary defects, removal of stones), minimally invasive operations on the urogenital tract, and organ-preserving kidney surgery in malignant neoplasms.
Selected publications from PubMed
Natural History of PI-RADS 3 Lesions on Serial Prostate mpMRI.
Bashi T, Rubinstein Y, Kidron A, Marom R, Rand Y, Atias M, Barnes S, Fahoum I, Keren-Paz G, Sofer M, Yossepowitch O, Dekalo S, Beri A, Mano R
Prostate. 2026 Aug 25 doi: 10.1002/pros.70240.
Personalizing BPH Management: Bladder Stone Removal Alone vs. With Concomitant Laser Enucleation-A Multicenter Perspective With Patient Reported Outcomes and Decisional Regret Analysis.
Savin Z, Mendelson T, Rahmani LD, Veredgorn Y, Frangopoulos E, Kaphle S, Huynh J, Hamlani A, Goldmann S, Yossepowitch O, Sofer M, Gupta M
Prostate. 2026 May;86(7):831-838 doi: 10.1002/pros.70155.
Transfer of a Guidewire Alongside a Nephrostomy Tube in Patients Undergoing Endourological Procedures.
Bashi T, Kidron A, Lipshitz K, Veredgorn Y, Yossepowitch O, Beri A, Sofer M, Nevo A
J Endourol. 2026 May;40(5):535-540 doi: 10.1177/08927790261420557.
Wide discrepancies between reported and actual resected prostate weight in HoLEP: a call for standardized reporting.
Mendelson T, Savin Z, Gildor OS, Fahoum I, Gauhar V, Yossepowitch O, Sofer M
World J Urol. 2026 Apr 5;44(1) pii: 277. doi: 10.1007/s00345-026-06388-z.
Applied trigonometry in elucidating the mechanism of post-HoLEP urinary incontinence.
Schwartztuch Gildor O, Mendelson T, Gomez Sancha F, Herrmann TR, Scoffone C, Aho T, Lusuardi L, de Figueiredo FCA, Aviram G, Nevo A, Yossepowitch O, Sofer M
World J Urol. 2025 Dec 4;44(1):19 doi: 10.1007/s00345-025-05943-4.
Dr. Mario Sofer (Israel) and his team at the Tel-Aviv Sourasky Medical Center (Israel) will perform an En bloc HoLEP with early release of external sphincter and mucosal dorsal flap preservation and will compare MoLEP with MOSES 2.0 to HoLEP and answer all your questions.
With Boston Scientific
Published
Sep 2022
Technique Description: Flexible ureteroscopy with single-use digital scope (LithoVue) Attempt at retrograde ablation by Thulium and Holmium lasers Possible conversion to supine percutaneous resection Procedure Steps: 1. Lithotomy position with slight elevation of right flank; scrubbing and draping for ECIRS 2. Removal of stent left 3 weeks ago during the diagnostic ureteroscopy and biopsy 3. Insertion of 2 guide wires (Sensor for safety and Zebra for insertion of ureteral access sheath UAS) 4. Insertion of UAS (11/13 Navigator) 5. Ureteroscopy, assessment of tumor location and size and attempt of laser ablation 6. Due to the tumor size, possible conversion to percutaneous resection in supine position: retrograde pyelography, renal puncture, dilation and percutaneous resection 7. Internal stenting (Percuflex 7/26) 8. If uneventful, tubeless procedure Learning Points: Flexible ureteroscopy with Thulium and Holmium laser ablation Supine US and X-ray guided puncture Percutaneous resection of tumor Tubeless approach Clinical History 63-year-old woman, heavy smoker Right upper calyx urothelial carcinoma Ta, low grade proven by flexible ureteroscopy and biopsy 3 weeks ago CT-Urography: 38 mm filling defect, right upper calyx, normal nephrography and urography, normal contralateral kidney Chest X-ray: emphysema, no other significant findings Cystoscopy: no bladder tumors Creatinine: within normal limits Urinary culture: negative
With Boston Scientific
Published
Apr 2020
Help your network discover Dr. Mario Sofer's clinical expertise.
